Skip to content

Clinical trials

Phase 2 Gastroparesis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroparesis Phase: Phase 2 Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20081
20095
20102
20113
20126
20132
20143
20152
20163
20171
20195
20201
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated8
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Tranzyme, Inc.4
CinDome Pharma, Inc.3
Johns Hopkins University2
Mayo Clinic2
Theravance Biopharma2
Allergan1
Chugai Pharma USA1
Dr. Falk Pharma GmbH1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroparesis43
Diabetes Mellitus10
Vomiting4
Diabetes Mellitus, Type 23
Gastroesophageal Reflux3
Nausea3
Anastomotic Leak2
Diabetes Complications2
Diabetes Mellitus, Type 12
Pancreatitis2

Trials

Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.